Goldstone Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$423K Buy
460
+90
+24% +$91.2K 0.05% 179
2025
Q4
$397K Buy
370
+49
+15% +$46.9K 0.04% 175
2025
Q3
$245K Buy
321
+4
+1% +$2.98K 0.03% 200
2025
Q2
$248K Sell
317
-80
-20% -$62.2K 0.03% 186
2025
Q1
$328K Sell
397
-23
-5% -$19.1K 0.05% 165
2024
Q4
$324K Buy
420
+127
+43% +$105K 0.05% 160
2024
Q3
$260K Sell
293
-158
-35% -$142K 0.05% 162
2024
Q2
$408K Buy
451
+88
+24% +$70.4K 0.08% 122
2024
Q1
$282K Buy
363
+10
+3% +$7.12K 0.06% 135
2023
Q4
$206K Buy
+353
New +$206K 0.05% 155

Other funds holding LLY

Goldstone Financial Group's LLY Position: Q1 2026 in Review

Goldstone Financial Group increased its Eli Lilly (LLY) stake by 24% in Q1 2026, buying an estimated $91.2K and bringing the position to 460 shares worth $423K. The position accounts for 0.05% of the portfolio, ranked #179.

Goldstone Financial Group first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Goldstone Financial Group held 460 shares of Eli Lilly worth $423K as of Q1 2026.
  • Goldstone Financial Group bought 90 Eli Lilly shares in Q1 2026, an estimated $91.2K.
  • Eli Lilly made up 0.05% of Goldstone Financial Group's portfolio in Q1 2026, its #179 holding.
  • Goldstone Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Goldstone Financial Group's 13F filing for Q1 2026, filed 24 Apr 2026.